Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
decrease risk » increased risk (Expand Search), increases risk (Expand Search), disease risk (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 81 - 100 results of 25,979 for search '(( significant decrease risk ) OR ( significantly ((mean decrease) OR (greater decrease)) ))', query time: 0.40s Refine Results
  1. 81
    Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery.

    Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 82
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test (<i>n</i> = 900).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test (<i>n</i> = 900). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 83
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up (<i>n</i> = 662).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up (<i>n</i> = 662). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 84
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 86
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 89
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by gender (<i>n</i> = 662).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by gender (<i>n</i> = 662). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 95
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by gender (<i>n</i> = 900).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by gender (<i>n</i> = 900). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 96
    Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis.

    Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 97
    SLE decreases risk for hormonal cancers.

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(a) Breast cancer incidence in female SLE cohort is significantly decreased by SLE status (OR 0.52, 95% CI 0.35, 0.74, p = 0.0036). …”
    Save to List
    Saved in:
  18. 98
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by age groups (<i>n</i> = 900).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test by age groups (<i>n</i> = 900). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 99
    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by age group (<i>n</i> = 662).

    Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up by age group (<i>n</i> = 662). by Maria Anna Donati (6735548)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 100
    Assessing model fit.

    Assessing model fit. by Jess A. Millar (2635135)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: